Analysts: Smith & Nephew ripe for acquisition — 7 key takeaways

Spinal Tech

Equity analysts are predicting that Smith & Nephew is ripe for an acquisition bid, according to a Morning Star report.

Here are seven key takeaways:

 

1. Analysts note that despite its relatively small size, Smith & Nephew has focused on meaningful innovation, thus becoming a significant contributor in the orthopedic device market.

 

2. Smith & Nephew pioneered its knee replacement device with Verilast technology, which, it claims, can last for 30 years.

 

3. This technology helps the company attract younger patients.

 

4. However, the company's small size, and hence relatively small market share, could work against the company.

 

5. Hospitals will likely stick with larger vendors whose products many orthopedic surgeons already use.

 

6. Thus, according to analysts, Smith & Nephew could pair up with another company to better compete in the market.

 

7. There were rumors over the past year that Stryker was interested in Smith & Nephew, however, the deal is no longer imminent.

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Podcast

Featured Whitepapers